Paintlia, Ajaib S <br/><br/>
Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis.  [electronic resource] 

 -  The American journal of pathology  Sep 2006 
 - 1012-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-9440 
<br/><br/><label>Standard No.: </label>10.2353/ajpath.2006.051309  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinases<br/>Aminoimidazole Carboxamide--administration & dosage<br/>Animals<br/>Dose-Response Relationship, Drug<br/>Drug Evaluation, Preclinical<br/>Drug Therapy, Combination<br/>Encephalomyelitis, Autoimmune, Experimental--drug therapy<br/>Enzyme Activation--drug effects<br/>Female<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage<br/>Hypoglycemic Agents--administration & dosage<br/>Immunoglobulin G--immunology<br/>Immunologic Factors--administration & dosage<br/>Lovastatin--administration & dosage<br/>Multienzyme Complexes--immunology<br/>Multiple Sclerosis--drug therapy<br/>Myelin Basic Protein--immunology<br/>Protein Serine-Threonine Kinases--immunology<br/>Rats<br/>Rats, Inbred Lew<br/>Ribonucleotides--administration & dosage<br/>Th1 Cells--immunology<br/>Th2 Cells--immunology